Growing footprint Zentiva serves over 100 million people across 40+ countries with four manufacturing sites and external manufacturing partners, indicating a broad regional reach and potential for multi-country formulation or packaging collaborations.

Acquisition chatter Recent high-profile M&A activity and interest from GTCR and Aurobindo Pharma in Zentiva suggest a dynamic ownership landscape and potential for strategic partnerships, divestitures, or license deals that could open new channels or markets.

Diversified portfolio Recent asset acquisitions from Aboca and licensing partnerships with Cinclus Pharma indicate Zentiva’s interest in natural-based consumer health solutions and primary lead candidates, signaling opportunities for OTC, dietary supplement, or combined Rx/OTC bundles.

Digital readiness Utilizes SAP, Hyperion, Qlik Sense and other enterprise tools, signaling a mature data-driven environment that can enable optimized supply planning, demand forecasting, and targeted cross-sell or up-sell programs across markets.

ESG and transparency Awarded ESG Transparency Award in 2025 and emphasis on privacy notice, highlighting a trust-rich brand: ideal for partnerships emphasizing compliant supply chains, sustainable sourcing, and joint initiatives in governance-focused markets.